Quality of life of women with breast cancer in a tertiary referral university hospital

Health Qual Life Outcomes. 2022 Jan 29;20(1):15. doi: 10.1186/s12955-022-01921-1.

Abstract

Background: Quality of life (QoL) is one of the treatment outcome measures in patients with breast cancer. In this study, we measured the QoL of women with breast cancer at Universiti Kebangsaan Malaysia Medical Centre (UKMMC) and identified the associated factors.

Methodology: This cross-sectional study was conducted from October 2017 to December 2017 and involved female patients with breast cancer. The QoL scores and domains were determined using the EuroQol EQ-5D-5L, and were presented as the utility value and visual analog scores, respectively.

Results: We recruited a total of 173 women, aged 33-87 years. The median VA score was 80.00 (interquartile range [IQR] 70.00-90.00); the median utility value was 0.78 (interquartile range [IQR] 0.65-1.00. Women who did not take traditional medicine had a higher utility index score of 0.092 (95% CI 0.014-0.171), and women with household income of RM3000-5000 had a higher utility index score of 0.096 (95% CI 0.011-0.180).

Conclusion: Traditional medicine consumption and household income were significantly associated with lower QoL. The pain/discomfort domain was the worst affected QoL domain and was related to traditional medicine use and household income. Addressing pain management in patients with breast cancer and the other factors contributing to lower QoL may improve the QoL of breast cancer survivors in the future.

Keywords: Breast cancer; Quality of life; Tertiary hospital.

MeSH terms

  • Breast Neoplasms* / therapy
  • Cross-Sectional Studies
  • Female
  • Humans
  • Quality of Life*
  • Referral and Consultation
  • Surveys and Questionnaires
  • Tertiary Care Centers